Comparing the effectiveness of two cardiovascular prevention programmes for highly educated professionals in general practice: A randomised clinical trial

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Claes, Neree ^a,b   Jacobs, Nele ^a   Clays, Els ^c   Schrooten, Ward ^a,d   De Bourdeaudhuij, Ilse ^c  

^a HASSELT UNIVERSITY   (Belgium)

^b ANTWERP MANAGEMENT SCHOOL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Cardiovascular diseases; General practice; Lifestyle programmes; Prevention

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL;

ADULT; AGED; ARTICLE; BELGIUM; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDUCATIONAL STATUS; FEMALE; FITNESS; FOLLOW UP; GENERAL PRACTICE; HEALTH EDUCATION; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL CARE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BELGIUM; CARDIOVASCULAR DISEASES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; GENERAL PRACTICE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME;

EID: 84878347797     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-38     Document Type: Article

References (27)

1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A. European Cardiovascular Disease Statistics. Edition 2005 2005, Oxford: Department of Public Health. University of Oxford.
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007, 14(Suppl 2):S1-S113.
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350. 10.1056/NEJM200105033441801, 11333990.
4. Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns 2008, 70:31-39. 10.1016/j.pec.2007.09.014, 17997263.
5. Laatikainen T, Dunbar J, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S, Philpot B, Absetz P, Bunker S, O'Neil A, Reddy P, Best JD, Janus ED. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Publ Health 2007, 7:249.
6. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Reiner Z, Keil UEUROASPIRE. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 2010, 17:530-540. 10.1097/HJR.0b013e3283383f30, 20577089.
7. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24(17):1601-1610. 10.1016/S0195-668X(03)00347-6, 12964575.
8. Buckley BS, Byrne MC, Smith SM. Service organisation for the secondary prevention of ischaemic heart disease in primary care. Cochrane Database Syst Rev 2010, 3:2010CD006772.
9. Claes N, Jacobs N. The PreCardio-study protocol-a randomized clinical trial of a multidisciplinary electronic cardiovascular prevention programme. BMC Cardiovasc Disord 2007, 7:27. 10.1186/1471-2261-7-27, 2045658, 17784946.
10. Prochaska JO, DiClemente CC. Stages of change in the modification of problem behaviors. Prog Behav Modif 1992, 28:183-218.
11. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24:1601-1610. 10.1016/S0195-668X(03)00347-6, 12964575.
12. Claes N, Nele J, van Mierlo J. The implementation costs of an electronic prevention programme in Belgian general practice. Eur J Gen Pract 2010, 16:12-17. 10.3109/13814780903540715, 20121647.
13. Vandelanotte C, Matthys C, De Bourdeaudhuij I. Reliability and validity of a computerised questionnaire to measure fat intake in Belgium. Nutr Res 2004, 24:621-631.
14. Vandelanotte C, De Bourdeaudhuij I, Philippaerts R, Sjöström M, Sallis M. Reliability and validity of a computerized and dutch version of the international physical activity questionnaire (IPAQ). J Phys Activ Health 2005, 2:63-75.
15. De Bourdeaudhuij I, Klepp KI, Due P, Rodrigo CP, de Almeida M, Wind M, Krolner R, Sandvik C, Brug J. Reliability and validity of a questionnaire to measure personal, social and environmental correlates of fruit and vegetable intake in 10-11-year-old children in five European countries. Public Health Nutr 2005, 8:189-200.
16. Jacobs N, De Bourdeaudhuij I, Thijs H, Dendale P, Claes N. Effect of a cardiovascular prevention program on health behavior and BMI in highly educated adults: a randomized controlled trial. Patient Educ Couns 2011, 85(1):122-126. 10.1016/j.pec.2010.08.024, 20888728.
17. Kelley GA, Kelley KS. Progressive resistance exercise and resting blood pressure : a meta-analysis of randomized controlled trials. Hypertension 2000, 35:838-843. 10.1161/01.HYP.35.3.838, 10720604.
18. Demarest S, Gisle L, Hesse E, Miermans PJ, Tafforeau J, Van der Heyden J. Belgian Health Interview Survey: Scientific Institute of Public Health 2004, Brussels, Belgium: Department Epidemiology.
19. Hansen D, Jacobs N, Bex S, D'Haene G, Dendale P, Claes N. Are fixed-rate step tests medically safe for assessing physical fitness?. Eur J Appl Physiol 2011, 111(10):2593-2599. 10.1007/s00421-011-1886-3, 21373866.
20. Redfern J, Briffa T, Ellis E, Freedman SB. Choice of secondary prevention improves risk factors after acute coronary syndrome: one year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial. Heart 2009, 95:468-475. 10.1136/hrt.2008.150870, 18801781.
21. Schuit AJ, Wendel-Vos GC, Verschuren WM, Ronckers ET, Ament A, Van Assema P, Van Ree J, Ruland EC. Effect of 5-year community intervention Hartslag Limburg on cardiovascular risk factors. Am J Prev Med 2006, 30:237-242. 10.1016/j.amepre.2005.10.020, 16476640.
22. Koelewijn-van Loon MS, van der Weijden T, van Steenkiste B, Ronda G, Winkens B, Severens JL, Wensing M, Elwyn G, Grol R. Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. Cmaj 2009, 181:E267-E274. 10.1503/cmaj.081591, 2789146, 19948811.
23. Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008, 371:1999-2012. 10.1016/S0140-6736(08)60868-5, 18555911.
24. Eriksson MK, Franks PW, Eliasson M. A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Bjorknas study. PLoS One 2009, 4:e5195. 10.1371/journal.pone.0005195, 2664964, 19365563.
25. Kotseva K. Lessons from EUROASPIRE I, II, and III surveys. Heart Metab 2011, 50:32-35.
26. Devroey D, Kartounian J, Vandevoorde J, Betz W, Cogge M, De Man B, De Ridder L, Block P, Van Gaal L. Primary prevention of coronary heart disease in general practice: a cross sectional population study. Int J Clin Pract 2004, 58:130-138. 10.1111/j.1368-5031.2004.0104.x, 15055860.
27. Chamnan P, Simmons RK, Khaw KT, Wareham NJ, Griffin SJ. Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ 2010, 340:c1693. 10.1136/bmj.c1693, 2859321, 20418545.